By Josh White
Date: Monday 04 Sep 2023
(Sharecast News) - UK-based biotechnology company ReNeuron Group, which specialises in stem cell-derived exosome technologies, announced significant advancements in the field of exosome research on Monday.
Creditor’s decision on Administrators' Pro... | 05-Jun-2024 | 15:36 | RNS |
Publication of Joint Administrators' Proposals | 17-May-2024 | 12:45 | RNS |
Update on Administration Process | 08-May-2024 | 07:00 | RNS |
Directorate Change | 17-Apr-2024 | 11:30 | RNS |
Appointment of Administrators | 20-Mar-2024 | 15:43 | RNS |
Reneuron tests stem cell stroke treatment | 03-Sep-2014 | The Herald |
ReNeuron unveils board shake-up as chairman move... | 21-Jul-2011 | The Scotsman |
ReNeuron shares in healthy shape | 04-Mar-2011 | The Scotsman |
ReNeuron shares surge on test results | 22-Dec-2010 | The Scotsman |
Reneuron raises £10m to fund trials | 14-Dec-2010 | The Scotsman |
Market report: Wednesday latest | 19-Mar-2008 | Daily Mail |
Xstrata shares rise as speculation grows of Vale... | 04-Jan-2008 | Telegraph |
Evolution shares not evolving | 04-Jan-2008 | Times |
The Investment Column: ReNeuron | 04-Dec-2007 | The Independent |
HMV expected to ring up dismal figures | 25-Jun-2007 | The Independent |
No recent information was found.
Currency | UK Pounds |
Share Price | 3.38p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 11.13 |
52 Week Low | 3.38 |
Volume | 0 |
Shares Issued | 57.17m |
Market Cap | £1.93m |
RiskGrade | 394 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
You are here: research